Multiple Sclerosis Agents

Random Miscellaneous Quiz

Can you name the Multiple Sclerosis Agents?

Quiz not verified by Sporcle

 plays        
How to Play
HintAnswer
Second line agent for RRMS that produces reduction in progression of disabilty
Mycophenolate class
Use: For pts who do not respond to corticosteroids during acute attacks
SE: HR reduction of 10-20 bpm, occasionally bradyarrhythmias or AV block -- screen for cardiac dz (6 hr monitoring w/ first dose). Macular edema in 1% (reversible). Check varicella
Fingolimod class
MOA: Synthetic form of myelin basic PRO copolymer 1. Binds to MHC molecules. Competes w/ myelin antigens for presentation to T cells.
SE: Risk of progressive multifocal leukoencephalopathy. Rare fatal viral (polymyxoma JC virus) reactivation infxn affecting white matter in immunosuppressed (only a risk to pts w/
Off line agent used in the treatment of acute attacks
Plasmapheresis class
MOA: Anti-organ rejection drug
Dose: 1250 mg/day PO for 3-5 days
SE: Localized inj site reactions. Self-limited (15-20 min) acute rxn resembling a panic attack (palpitations, dyspnea, flushing) -- not an indication to stop tx
Prednisone class
Second line agent given IV monthy
MOA: Purine analog
Use: treatment of spasticity
SE: Seizures at higher than recommended doses (contraindicated in pts with a hx of seizure)
Methylphenidate class
SE: Thyroid disorders, ITP (with fatal brain hemorrhage), infections.
Baclofen class
IFN beta 1-b (Betaseron) class
Mitoxantrone class
MOA: Potassium channel blocker. Possibly increases conduction in demyelinated axons
HintAnswer
Modafinil class
Daclizumab class
Carbamazepine class
Methylprednisone class
Methotrexate class
Use: Depression. Also helps with pain
Dose: 1 gram/day IV for 3-5 days
Bupropion class
MOA: Immune modulator, exact mechanism not known.
Tricyclic class
Dalfampridine class
Excreted by kidney: contraindicated in moderate to severe renal failure
Dose: SC injection every other day
MOA: Monoclonal Ab. Shows functional improvement not just slowing of decline
Natalizumab class
Axathioprine class
Cyclophosphamide class
MOA: Immunomodulator/antineoplastic
Glatiramer acetate class
Use: pain and paroxysmal disorders
Second line agent: RRMS, SPMS, Progressive Relapsing MS
Dose: SC injection 2-3 times weekly
Second line agent: RRMS. Reduced relapses & progression of disability
HintAnswer
First line drugs for disease modification
Duloxetine class
Rituximab class
Dose: Oral daily (first PO MS drug)
Dose: Oral. In extreme cases intrathecal
Venlafaxine class
Use: Depression. Also helps with fatigue
Second line agent MOA: monoclonal Ab
Dose: IV infusion every 3 months
IFN beta 1-a (Rebif) class
Dose: IM weekly
MOA: alkylating agent
MOA: Sphingosine 1-phosphate receptor modulator. Sequesters lymphocytes.
First line RRMS agent injected SC daily
Use: Fatigue
MOA: Antimetabolite and antifolate
SE: Inj site rxn w/ high doses, flu-like s/s (responds well to naproxen), monitor liver fx, may develop neutralizing Ab, may increase depression.
Tizanidine class
Use: Fatigue, cognitive impairment (long acting agent)
IFN beta 1-a (Avonex) class
Alemtizumab class
Gabapentin class

Friend Scores


  Player Best Score Plays Last Played
You You haven't played this game yet.

You Might Also Like...

Extras

Created Oct 18, 2011ReportNominate
Tags:agent, multiple